Skip to main content
MarketStoryBook

Scholar Rock Holding Corporation in 1 story

The narratives SRRK currently appears in, with its side and exposure in each.

Bull side

1 story
  • GLP-1 Eats Everything

    SRRK in “GLP-1 Eats Everything”

    FadingExposure: not rated yet

    Appetite suppression as a macro variable.

    Scholar Rock is developing muscle-preservation therapies intended to complement GLP-1 weight loss and address loss of lean mass.

Bear side

0 stories

No bear-side stories for SRRK yet.